Is it True that the Corona Virus will take a Few Years to Get Completely Eradicated?

{"title":"Is it True that the Corona Virus will take a Few Years to Get Completely Eradicated?","authors":"","doi":"10.31829/2641-7456/ahs2020-4(1)-149","DOIUrl":null,"url":null,"abstract":"Lots of hope but also illusions. It all depends on the future vaccine [1]that will allow human protection against the Corona (COVID 19) disease. \n\nThe disease caused by SARS-CoV-2, termed COVID-19, is multifactorial and associated with both specific antiviral as well as inflammatory responses, the extent of which may determine why some individuals are asymptomatic while others develop serious complications. Here we review possible life-threatening immune events that may occur during disease progression to uncover key factors behind COVID-19 severity and provide suggestions for interventions with repurposed drugs in well-controlled and randomized clinical trials. These drugs include therapeutics with potential to inhibit SARS-CoV-2 entry into host cells such as serine protease inhibitors of the TMPS2 cellular protease and drugs targeting the renin-angiotensin system; antivirals with potential to block SARS-CoV-2 replication or factors that could boost the antiviral response; monoclonal antibodies targeting pro-inflammatory cytokines that drive the hyper inflammatory response during COVID-19 progression toward the severe stage and therapeutics that could ameliorate the function of the lungs. Furthermore, in order to help make more informed decisions on the timing of the intervention with the drugs listed in this review, we have grouped these therapeutics according to the stage of COVID-19 progression that we considered most appropriate for their mechanism of action.[2]","PeriodicalId":127914,"journal":{"name":"Archives of Health Science","volume":"42 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Health Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31829/2641-7456/ahs2020-4(1)-149","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Lots of hope but also illusions. It all depends on the future vaccine [1]that will allow human protection against the Corona (COVID 19) disease. The disease caused by SARS-CoV-2, termed COVID-19, is multifactorial and associated with both specific antiviral as well as inflammatory responses, the extent of which may determine why some individuals are asymptomatic while others develop serious complications. Here we review possible life-threatening immune events that may occur during disease progression to uncover key factors behind COVID-19 severity and provide suggestions for interventions with repurposed drugs in well-controlled and randomized clinical trials. These drugs include therapeutics with potential to inhibit SARS-CoV-2 entry into host cells such as serine protease inhibitors of the TMPS2 cellular protease and drugs targeting the renin-angiotensin system; antivirals with potential to block SARS-CoV-2 replication or factors that could boost the antiviral response; monoclonal antibodies targeting pro-inflammatory cytokines that drive the hyper inflammatory response during COVID-19 progression toward the severe stage and therapeutics that could ameliorate the function of the lungs. Furthermore, in order to help make more informed decisions on the timing of the intervention with the drugs listed in this review, we have grouped these therapeutics according to the stage of COVID-19 progression that we considered most appropriate for their mechanism of action.[2]
冠状病毒真的需要几年时间才能完全根除吗?
希望和幻想并存。这一切都取决于未来的疫苗[1],它将使人类免受冠状病毒(COVID - 19)疾病的侵害。由SARS-CoV-2引起的疾病被称为COVID-19,是多因素的,与特定的抗病毒反应和炎症反应有关,其程度可能决定了为什么有些人无症状,而另一些人则出现严重并发症。在此,我们回顾了在疾病进展过程中可能发生的危及生命的免疫事件,以揭示COVID-19严重程度背后的关键因素,并在对照良好的随机临床试验中为重新定位药物的干预提供建议。这些药物包括可能抑制SARS-CoV-2进入宿主细胞的治疗药物,如TMPS2细胞蛋白酶的丝氨酸蛋白酶抑制剂和靶向肾素-血管紧张素系统的药物;有可能阻断SARS-CoV-2复制的抗病毒药物或可能增强抗病毒反应的因素;针对在COVID-19进展到严重阶段期间驱动超炎症反应的促炎细胞因子的单克隆抗体和可以改善肺功能的治疗方法。此外,为了帮助更明智地决定使用本综述中列出的药物进行干预的时机,我们根据我们认为最适合其作用机制的COVID-19进展阶段对这些治疗方法进行了分组
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信